Recovery Through Inhibitory Learning, Self-Efficacy Building, Problem Solving, and Community Building

Last updated: December 1, 2025
Sponsor: University of Rhode Island
Overall Status: Active - Recruiting

Phase

N/A

Condition

Addictions

Post-traumatic Stress Disorders

Alcohol Dependence

Treatment

Wait-List Control

CBT + expressive writing

Clinical Study ID

NCT07217795
2310793
  • Ages > 18
  • All Genders

Study Summary

This is a two-part study to develop and test a brief, virtual therapy program for lesbian, gay, bisexual, transgender, and queer (LGBTQ+) people who have experienced trauma and use alcohol.

Phase 1: You'll be invited to share your perspective to help make the program relevant, inclusive, and affirming.

Phase 2: You may have the opportunity to try the adapted program by receiving free virtual therapy with LGBTQ+-affirming therapists.

Eligibility Criteria

Inclusion

Aim 1: Sexual Minority Women and Transgender and Gender Diverse Individuals -Not meeting inclusion criteria

Aim 1: Providers

-Not meeting inclusion criteria

Aim 2: Sexual Minority Women and Transgender and Gender Diverse Individuals

  • Not meeting inclusion criteria OR any of the following:

  • Reporting current mental health treatment ≥1 day/month

  • Receiving Cognitive Behavioral Therapy (CBT) in the past 3 months (note: participants are not ineligible if they seek concomitant care after enrollment)

  • Reporting current alcohol or drug use disorder treatment, except mutual self-help (e.g., Alcoholics Anonymous) or current PTSD/trauma-focused treatment

  • Need for alcohol detoxification, defined as score ≥15 on the adapted self-report Clinical Institute Withdrawal Assessment for Alcohol - Revised (CIWA-Ar)

  • Active psychosis, defined as score ≥1 on the psychosis subscale of the Behavior and Symptom Identification Scale - Revised (BASIS-R)

  • Active mania, defined as score ≥6 on the Altman Self-Rating Mania Scale (ASRM)

  • Active suicidality, defined as score ≥22 on the Suicidal Ideation Attributes Scale (SIDAS)

  • Currently legally mandated to attend treatment

Study Design

Total Participants: 80
Treatment Group(s): 2
Primary Treatment: Wait-List Control
Phase:
Study Start date:
November 30, 2025
Estimated Completion Date:
September 30, 2028

Connect with a study center

  • University of Rhode Island

    Providence 5224151, Rhode Island 5224323 02860
    United States

    Active - Recruiting

Map preview placeholder

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.